Otto Kauko
Publications
- Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A (2023)
- Nature Communications
(A1 Refereed original research article in a scientific journal) - Arginine Methyltransferase PRMT7 Deregulates Expression of RUNX1 Target Genes in T-Cell Acute Lymphoblastic Leukemia (2022)
- Cancers
(A1 Refereed original research article in a scientific journal) - The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer (2021)
- Cell
(A1 Refereed original research article in a scientific journal) - Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1 (2020)
- Journal of Biological Chemistry
(A1 Refereed original research article in a scientific journal) - Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia (2019)
- Cancers
(A1 Refereed original research article in a scientific journal) - Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer (2018)
- International Journal of Biochemistry and Cell Biology
(A2 Refereed review article in a scientific journal ) - Phosphonormalizer: an R package for normalization of MS-based label-free phosphoproteomics (2018)
- Bioinformatics
(A1 Refereed original research article in a scientific journal) - PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells (2018)
- Science Translational Medicine
(A1 Refereed original research article in a scientific journal) - A Systems Biology Analysis of PP2A Functions in Cancer Cells (2017) Kauko Otto
(G5 Article dissertation ) - Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56 (2017)
- EMBO Reports
(A1 Refereed original research article in a scientific journal)



